BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
DIAGNOSIS: The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the
WEBINAR: You are cordially invited to a conversation with Dr. David Holtzman about his PrecivityAD groundbreaking new blood test to aid in the diagnosis of
TEEPA VIDEO: How do I stay protected from Coronavirus, when caring for a physically healthy person with dementia? Physical contact is unavoidable — forget 6
RESEARCH: Scientists are using gold nanoparticles to create new images of the amyloid fibrils associated with Alzheimer’s disease and other neurodegenerative disorders. The fibrils are
Woolsey Pharmaceuticals on Feb. 18, 2021 announced the launch of a Phase 2 CNS study of a medication intended to reduce wandering in dementia patients.
THE CORONA VIRUS: Around the world, dementia researchers are studying SARS-CoV-2 virus’ (the cause of COVID-19) long-term effects on the brain and nervous system. It
ALZFORUM: Last year, people with dementia were most vulnerable, and this constrained research. Investigators adjusted and managed to make strides in important areas, from plasma
Please enter your request in the comments box below.
“Alzheimer’s Sheds” offer productive activities in early-stage dementia. See one run by Alzheimer’s Australia NSW and the Australian Men’s Shed Association. See it reduce social isolation, while contributing to the community.
Can something as simple as a good night’s sleep help prevent and even slow down Alzheimer’s?
AAIC 2024 is the Alzheimer’s Association’s International Conference. The world’s leading scientists, researchers, and clinicians gather to discuss the latest discoveries and upcoming research. Ranging from new biomarker blood tests to VR technology, see exciting and promising news coming from the 2024 conference.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
